Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2017

View Archived Issues

FDA clinical hold on Concert Pharmaceuticals' trial of CTP-543 lifted

FDA gives orphan drug status to Boston Biomedical's DSP-7888

Prexton Therapeutics begins phase II testing of Parkinson's disease candidate

YH-18421 shows promise in diabetic mouse model

Global Blood Therapeutics expands phase IIa study of GBT-440

Immuron presents promising interim analysis results from phase II NASH trial of IMM-124E

Hemispherx gives update on early access program of Ampligen in pancreatic cancer

Lilly's abemaciclib NDA granted priority review by FDA

PDS and Merck & Co. sign clinical trial collaboration to study PDS-0101 with Keytruda

Eculizumab as potential therapy for certain forms of protein-losing enteropathy

Boehringer Ingelheim Pharma patents polypeptides targeting LRP5 and LRP6

Phenex Pharmaceuticals reaches milestone in Janssen collaboration

Anti-shingles nanoviricides drug candidates inhibit infection ex vivo

Long-acting human GLP-1 analogue BPI-3016 demonstrates promise in preclinical studies

Vaccines targeting personal tumor neoantigens show promise in patients with melanoma

Race Oncology, TargImmune create joint venture

Merus shareholders vote in favor of Norgine transaction

Enterome and Nestle Health create Microbiome Diagnostics Partners

Medicure exercises option to acquire additional interests in Apicore

G47DELTA designated a Japanese orphan drug for malignant glioma

Scancell updates SCIB-1 progress in melanoma

Arena reports phase II results for ralinepag in PAH

Alimera secures rights to Iluvien for posterior uveitis in E.U.

Neothetics seeks strategic alternatives

Sanofi set to acquire Protein Sciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...